Latest diazepam Stories
SAN DIEGO, June 14, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the results of a randomized crossover study in healthy volunteers assessing diazepam pharmacokinetics and bioavailability after administration of their proprietary intranasal diazepam formulations and intravenous injection.
SAN DIEGO, April 20, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
When seizures strike, the most immediate goal for caregivers is to get appropriate medication to the patient as quickly as possible to stop the seizing activity.
BEVERLY HILLS, Calif., Aug.
Researchers believe they may have discovered a more sophisticated anti-anxiety drug capable of controlling panic attacks without the hefty side effects associated with most currently available treatments.
READING, England, February 26 /PRNewswire/ -- - Intranasal Apomorphine for the Treatment of Motor Fluctuations in Advanced Parkinson's Disease - Intranasal Diazepam for the Treatment of Acute Repetitive Seizures in Epilepsy - Phase II Trials on Both Projects to be Initiated During 2009 Archimedes Pharma Limited, the pan-European specialty pharmaceutical company, today announces positive headline data from its recently completed proof-of-concept trials for two of its...
Valeant Pharmaceuticals (NYSE:VRX) today announced that it has signed an agreement with GlaxoSmithKline (NYSE:GSK) for the promotion of Diastat(R) and Diastat(R) AcuDial(TM), the first and only FDA-approved, acute at-home medication for patients two years and older on stable antiepileptic medications (AEDs) who experience bouts of increased seizure activity, sometimes called serial or cluster seizures or breakthrough seizures.
Analysts in the UK have reported a surge in popularity of the drug diazepam, better known as Valium, among drug users.
There is strong evidence that THC, the main psychoactive component of marijuana, crosses the placenta, that maternal marijuana abuse results in intrauterine growth retardation and that infants exposed to marijuana exhibit a temporary syndrome that includes lethargy and decreased muscle tone.
By Bennett, W R Murray Wilson, Lawrence G; Roy-Byrne, Peter P Abstract- GHB is an increasingly popular drug of abuse that can be associated in select cases with growing dependence and a severe withdrawal syndrome.